Kalorama: Expect More Acquisitions in IVD

NEW YORK, Nov. 11, 2015 /PRNewswire/ -- In an effort to boost market share, in vitro diagnostic (IVD) companies have been very active in 2015 with respect to acquisitions, and Kalorama Information sees that trend continuing.  The firm says that no company, big or small, owns all of the technology needed to develop new tests and systems. They have to gain the pieces they do not have via acquisitions and partnerships, with some 240 significant acquisitions alone having taken place from 2012 to October 2015. The healthcare market research publisher's report, Mergers and Acquisitions in the IVD Market, shows how dynamic the IVD industry currently is, recording and examining these transactions.

Mergers and Acquisitions in the IVD Market can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=88031&productid=9368424.  

IVD products are those reagents, instruments, and systems intended for use in diagnosis of disease or other conditions.  The goal in the IVD industry is to build better tests and stronger companies. The future of the industry lies in the development of more sensitive, faster, user-friendly, IT-capable devices for a host of new protein and molecular markers. 

IVD companies pursue mergers and acquisitions to acquire new IVD technologies, enter new segments of the IVD market, counter competitors, or open distribution channels.  Recent acquisitions illustrate this, such as OPKO Health's August acquisition of Bio-Reference Laboratories (BRL), with which OPKO feels Bio-Reference's national infrastructure, reach and extensive payer network will be invaluable to the adoption of OPKO's 4Kscore test by physicians and patients across the U.S.  BD's (Becton, Dickinson and Company) recent acquisition of Cellular Research was seen as a path to a new IVD technology, to developing a genomics platform for single cell analysis.

Strengthened by these many acquisitions, the goal of the IVD industry is to move beyond interoperability challenges and refocus energy on advancing healthcare. Next steps include the creation of the coming generation of IVD products, which will integrate the clinical lab into the mainstream of healthcare information flow.

Mergers and Acquisitions in the IVD Market can be found at Kalorama Information: http://www.kaloramainformation.com/redirect.asp?progid=88031&productid=9368424.

About Kalorama Information
Kalorama Information, a division of MarketResearch.com, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on www.marketresearch.com and www.profound.com.

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at www.kaloramainformation.com.  

Contact:
Bruce Carlson
(212) 807-2622
[email protected]
www.KaloramaInformation.com

Logo - http://photos.prnewswire.com/prnh/20150831/262422LOGO

SOURCE Kalorama Information